Progressive Corp vs 22nd Century Group Inc — how do they compare? Progressive Corp trades at $215.8 (market cap $125.23B), while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). The key difference: Progressive Corp is far larger — about 83486.7× 22nd Century Group Inc's market cap, and Progressive Corp pays a 0.19% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| PGR | XXII | |
|---|---|---|
Market Cap | $125.23B | $1.50M |
Sector | Financials | Technology |
52-Week High | $248.80 | $594.00 |
52-Week Low | $190.40 | $2.13 |
Enterprise Value | $133.44B | -$2.81M |
Dividend Yield | 0.19% | — |
Signals from Pluang's Aura AI — not financial advice
Progressive (PGR) trades at $214.9, down 1.85% today, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 10.78, net income margin of 12.85%, and ROE of 34.94%, supported by revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent earnings beat expectations in Q4 2025 and Q2 2026, but missed in Q1 2026. News highlights competition in auto insurance and telematics advantages.
Outlook is mixed: analyst consensus targets $231.18 with 38.1% buy ratings, but technical weakness and competitive pressures pose risks. Investment opportunity lies in valuation discounts and operational strength, though expense increases and market volatility require caution.
XXII trades at $2.29, down 4.58% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a Q2 2026 EPS miss of -15.6 versus -6 expected, with negative gross and net income margins. Recent news highlights VLN brand expansion and a 20:1 reverse stock split effective June 12, 2026.
Outlook is challenged by persistent losses and high cash burn, though analyst consensus is 75% buy. Key risks include execution on commercialization and profitability turnaround. The stock's low valuation multiples may attract speculative interest if operational improvements materialize.
Trailing returns across standard periods
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →